Jiangsu Jibeier Pharmaceutical Co., Ltd. (SHA:688566)
China flag China · Delayed Price · Currency is CNY
25.79
-0.16 (-0.62%)
Sep 10, 2026, 1:14 PM CST

SHA:688566 Cash Flow Statement

Millions CNY. Fiscal year is Jan - Dec.

Operating Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Net Income
209.14261.61219.33219.09154.67114.9
Depreciation & Amortization
2217.7110.711.212.7512.98
Other Amortization
0.580.750.81.071.091.09
Loss (Gain) From Sale of Assets
----0.01-
Asset Writedown & Restructuring Costs
0-----
Loss (Gain) From Sale of Investments
3.180.8140.850.48-5.68-17.26
Provision & Write-off of Bad Debts
-2.62-2.622.267.20.73-1.77
Other Operating Activities
-2.17-1.67-0.591.81-0.4-0.55
Change in Accounts Receivable
-25.09-61-24.28-138.14-72.0842.96
Change in Inventory
4.743.61-1.191.12-0.830.28
Change in Accounts Payable
-15.7211.58-37.638.4739.43-8.6
Change in Other Net Operating Assets
35.1223.036.8117.8921.517.33
Operating Cash Flow
224.49248.3215.29159.5150.72150.56
Operating Cash Flow Growth
-6.86%15.33%34.98%5.82%0.11%28.28%

Investing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Capital Expenditures
-87.4-114.6-174.53-357.37-292.7-83.79
Sale of Property, Plant & Equipment
-0.020--0.010
Cash Acquisitions
-20.38-20.38----
Investment in Securities
-117.22-142.6-51-15108.8-270
Other Investing Activities
-237.2535.368.338.4120.64
Investing Cash Flow
-462.26-274.57-220.17-364.04-175.49-333.15

Financing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Short-Term Debt Issued
-63.8539.2619.74--
Total Debt Issued
63.8563.8539.2619.74--
Total Debt Repaid
-2.2-----
Net Debt Issued (Repaid)
61.6563.8539.2619.74--
Issuance of Common Stock
19.41-222.2924.29--
Common Dividends Paid
-104.14-103.7-102.95-44.87-89.73-89.73
Other Financing Activities
-20.47--1.31-0.4--
Financing Cash Flow
-43.56-39.86157.3-1.23-89.73-89.73

Net Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Net Cash Flow
-281.33-66.13152.42-205.77-114.5-272.32

Free Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Free Cash Flow
137.09133.7140.76-197.87-141.9866.77
Free Cash Flow Growth
44.43%228.01%----28.73%
Free Cash Flow Margin
13.70%13.84%4.55%-22.98%-21.68%13.10%
Free Cash Flow Per Share
0.690.670.21-1.06-0.760.35
Levered Free Cash Flow
104.0675.19-10.03-303.05-187.7385.4
Unlevered Free Cash Flow
104.2275.36-9.95-302.99-187.585.4

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash Income Tax Paid
177.3152.97141.4293.8383.3683.52
Change in Working Capital
-5.62-28.28-58.05-81.35-12.4441.18